Used in research to selectively inhibit matrix metalloproteinase-13 (MMP-13), an enzyme involved in the breakdown of extracellular matrix components. This inhibition is particularly relevant in studying diseases associated with tissue degradation, such as osteoarthritis and certain cancers. By targeting MMP-13, MMP13-IN-3 helps in evaluating the enzyme's role in disease progression and in exploring potential therapeutic strategies. It is primarily employed in biochemical assays and cellular models to assess efficacy, selectivity, and signaling pathways related to MMP-13 activity.